FIG4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.719100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.757700E-02
Normal-vs-Stage2
4.082600E-03
Normal-vs-Stage3
2.799700E-02
Normal-vs-Stage4
1.202400E-01
Stage1-vs-Stage2
8.831000E-01
Stage1-vs-Stage3
4.367600E-01
Stage1-vs-Stage4
2.459200E-01
Stage2-vs-Stage3
2.642000E-01
Stage2-vs-Stage4
2.261400E-01
Stage3-vs-Stage4
4.631800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.162180E-02
Normal-vs-AfricanAmerican
3.937500E-02
Normal-vs-Asian
1.921570E-02
Caucasian-vs-AfricanAmerican
7.424600E-01
Caucasian-vs-Asian
6.201000E-01
AfricanAmerican-vs-Asian
5.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.263200E-03
Normal-vs-Female
1.507650E-02
Male-vs-Female
5.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.142500E-02
Normal-vs-Age(41-60Yrs)
2.645500E-02
Normal-vs-Age(61-80Yrs)
9.779100E-03
Normal-vs-Age(81-100Yrs)
7.918500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.360800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.818600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.855200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.052200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.831400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.511200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.082100E-02
Normal-vs-Daily Drinker
6.022300E-04
Normal-vs-Weekly Drinker
1.757370E-03
Normal-vs-Occasional Drinker
2.051600E-01
Normal-vs-Social Drinker
5.222300E-02
Non Drinker-vs-Daily Drinker
1.720190E-01
Non Drinker-vs-Weekly Drinker
7.045200E-01
Non Drinker-vs-Occasional Drinker
5.398400E-01
Non Drinker-vs-Social Drinker
6.041600E-01
Daily Drinker-vs-Weekly Drinker
2.473600E-01
Daily Drinker-vs-Occasional Drinker
1.415950E-01
Daily Drinker-vs-Social Drinker
6.099600E-02
Weekly Drinker-vs-Occasional Drinker
4.114000E-01
Weekly Drinker-vs-Social Drinker
3.787600E-01
Occasional Drinker-vs-Social Drinker
8.919000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.399600E-01
Normal-vs-Grade 2
7.060400E-02
Normal-vs-Grade 3
9.418300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.612200E-01
Grade 1-vs-Grade 3
5.444000E-01
Grade 1-vs-Grade 4
2.399600E-01
Grade 2-vs-Grade 3
7.214800E-01
Grade 2-vs-Grade 4
7.060400E-02
Grade 3-vs-Grade 4
9.418300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.764000E-02
Normal-vs-NonDiabetic
3.558100E-03
Diabetic-vs-NonDiabetic
6.466600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.024050E-02
Normal-vs-NoPancreatitis
1.099550E-02
Pancreatitis-vs-NoPancreatitis
5.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.464300E-02
Normal-vs-N1
2.196500E-03
N0-vs-N1
2.114800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.179700E-04
Normal-vs-TP53-NonMutant
3.736000E-02
TP53-Mutant-vs-TP53-NonMutant
3.820100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
